[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100400862":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":24,"studyPopulation":13,"armGroups":25,"interventions":36,"overallOfficials":44,"centralContacts":52,"locations":58,"responsibleParty":75,"collaborators":13,"id":78,"slug":13,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":13,"eligibilityCriteria":83,"healthyVolunteers":79,"sex":84,"minAge":13,"maxAge":85,"enrollmentInfo":86,"targetDuration":13,"studyType":89,"phases":90,"briefSummary":81,"conditions":92,"keywords":13,"overallStatus":61,"whyStopped":13,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Tanta University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Number of patients with improved glasgow coma score","The number of patients with improved glasgow coma score","2 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":20},"TRIPLE",[21,22,23],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","The study aims to study the Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics",[26,32],{"label":27,"type":28,"description":29,"interventionNames":30},"Nucleo CMP forte","EXPERIMENTAL","Nucleo CMP forte twice daily for 6 weeks with supportive treatment.",[31],"Drug: Nucleo CMP Forte",{"label":33,"type":34,"description":35,"interventionNames":13},"Supportive treatment","NO_INTERVENTION","Supportive treatment only.",[37],{"type":38,"name":39,"description":40,"armGroupLabels":41,"otherNames":42},"DRUG","Nucleo CMP Forte","Nucleo CMP Forte twice daily for 6 weeks",[27],[43],"Nucleoforte",[45,49],{"name":46,"affiliation":47,"role":48},"Abeer Salamah, Lecturer","Pediatrics department - Kafr-Elsheikh University","PRINCIPAL_INVESTIGATOR",{"name":50,"affiliation":51,"role":48},"Mohamed Elbahnasawy, lecturer","Emergency Department- Tanta University.",[53],{"name":54,"role":55,"phone":56,"phoneExt":13,"email":57},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[59],{"facility":60,"status":61,"city":62,"state":13,"zip":13,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":71},"Sherief Abd-Elsalam","RECRUITING","Tanta","Egypt","EG",{"type":66,"coordinates":67},"Point",[68,69],31.00192,30.78847,{"lat":69,"lon":68},[72],{"name":73,"role":55,"phone":74,"phoneExt":13,"email":57},"Sherief Abd-Elsalam, Ass. Prof.","00201009221243",{"type":76,"investigatorFullName":60,"investigatorTitle":77,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"SPONSOR_INVESTIGATOR","Ass. Prof. Tropical Medicine","100400862",false,"NCT04499755","Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics","Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Children with traumatic brain injury: Moderate and Severe.\n\nExclusion Criteria:\n\n* Underlying CNS disorders,","ALL","18 Years",{"count":87,"type":88},100,"ESTIMATED","INTERVENTIONAL",[91],"PHASE3",[93],"Brain Injuries","2020-08-01",{"date":96,"type":97},"2020-08-05","ACTUAL",{"date":99,"type":97},"2020-06-01",{"date":101,"type":88},"2030-12-10",{"name":60,"class":6},1]